Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(11/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(11/week)
News
United States
(530/week)
Manufacturing
(352/week)
Energy
(282/week)
Technology
(363/week)
Other Manufacturing
(284/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Tyrosine kinase receptors
Feb 21, 2018
Bayer Announces Publication of Larotrectinib Data in The New England Journal of Medicine
Jan 30, 2018
BridgeBio Pharma Licenses Late-Stage Oncology Drug Infigratinib to Tackle FGFR-Driven Maladies; Establishes New Subsidiary QED Therapeutics with $65 Million in Initial Financing
Jan 30, 2018
WuXi Biologics Congratulates BioAtla on FDA Clearance of IND Application for CAB-AXL-ADC
Jan 29, 2018
BerGenBio: Encouraging I-O Clinical Data With Selective AXL Inhibitor Bemcentinib (BGB324) Supports its Potential as Cornerstone of Cancer Therapy
Jan 24, 2018
Bioatla Announces FDA Clearance Of Investigational New Drug Application For CAB-AXL-ADC Therapeutic
Jan 18, 2018
QIAGEN Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer
Jan 16, 2018
FDA approves new indication for Gilotrif® in EGFR mutation-positive NSCLC
Jan 09, 2018
BerGenBio Meets First Efficacy Endpoint in Phase II Trial With Selective AXL Inhibitor BGB324 (bemcentinib) in NSCLC
Dec 20, 2017
Bayer Announces that Loxo Oncology, Inc., Initiates Rolling NDA Submission for Larotrectinib for the Treatment of TRK Fusion Cancers
Dec 13, 2017
WNT Signaling Pathway Inhibitors Therapeutics Pipeline Analysis 2017: Key Players are Samumed, Can-Fite BioPharma & Tactical Therapeutics
Dec 12, 2017
Paradigm Diagnostics Announces Fusion Panel Addition to PCDx
Dec 04, 2017
Updated larotrectinib pediatric Phase I clinical trial data demonstrates response in TRK fusion cancers
Nov 15, 2017
LUNGevity Partners with ALK Positive Patient Group to Fund Lifesaving Research
Nov 14, 2017
Data at SABCS and ASH Demonstrate Daiichi Sankyo Commitment to Advancing Science in Breast and Blood Cancer
Nov 01, 2017
Blueprint Medicines Announces Publication of BLU-285 Translational Data
Oct 30, 2017
Merrimack Receives Orphan Drug Designation for MM-121 for the Treatment of Heregulin Positive Non-small Cell Lung Cancer
Aug 31, 2017
Daiichi Sankyo Showcases New Insights on Multiple Oncology Compounds at the European Society for Medical Oncology (ESMO) 2017 Congress
Aug 16, 2017
Trovagene's PLK1 Inhibitor PCM-075, in Preclinical AML Data, Significantly Enhances the Efficacy of a FLT3 inhibitor in Combination Therapy
Aug 15, 2017
The Addario Lung Cancer Medical Institute, Champions Oncology and Motivated Patients Announce a Research Collaboration and Launch of a Patient Driven Clinical Study in ROS1 Positive Cancer
Jun 22, 2017
The Lancet Oncology Publishes Anti-Leukemic Activity and Safety Data for gilteritinib in Relapsed/Refractory Acute Myeloid Leukemia
‹‹
Page 6
››
Latest News
Apr 20, 2024
T2EARTH Celebrates Earth Day by Leading the Wood Products Industry towards a Sustainable Built Environment
Apr 20, 2024
Port Houston Regular Commission Meeting
Apr 20, 2024
LS Cable & System Welcomes $99 Million Investment Tax Credit Under Section 48C of the Inflation Reduction...
Apr 20, 2024
Taiwan's defence ministry detects 21 Chinese military aircraft
Apr 20, 2024
Taiwan detects 21 Chinese military aircraft: defence ministry
Apr 20, 2024
Biloxi Marsh Lands Corporation Announces Unaudited Results for the First Quarter of 2024
Apr 20, 2024
Evergy Schedules Conference Call to Discuss 1st Quarter Results
Apr 20, 2024
Stem Announces Appointment of AI Industry Leader as New Independent Director
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events